Lightyear Capital invests in CuraLinc Healthcare
Summary
US-based private equity company Lightyear Capital has completed a strategic investment in CuraLinc Healthcare, a provider of mental health care and well-being programmes.Financial details of the investment have not been disclosed.The latest move is aimed at bolstering the next phase of growth for CuraLinc, which specialises in offering workforce mental health benefits.Founded in 2008, the company has become a key player in the mental health sector, supporting approximately nine million employees and students globally.The companys reach extends to more than 4,200 clients.CuraLincs services are designed to engage and support individuals in their mental health journey, offering a range of programmes, including employee assistance, mental health counselling, and digital cognitive behavioural therapy.The comprehensive suite of services provided by CuraLinc includes crisis support, group therapy, text therapy, digital and mental health navigation and advocacy.All these programmes are tailored to meet the needs of both employees and students, ensuring accessible and effective mental health care.CuraLinc founder and president Sean Fogarty said: We believe we will benefit from Lightyears deep domain expertise in employee benefits and mental health care, expansive operating network, and strong reputation as a preferred partner to management teams.With this new capital and collaboration, we will drive continued growth and innovation to better serve our customers.Legal counsel for the transaction was provided by Davis Polk & Wardwell to Lightyear and Locke Lord to CuraLinc.Financial advisory services were rendered by Houlihan Lokey and The Chicago Corporation for Lightyear and CuraLinc, respectively.Lightyear managing director Michael Langer said: Access to care and treatment for mental health issues remains out of reach for most of the US population even though approximately one in four adults experiences mental illness each year.The average wait time for behavioural health counselling is six weeks, and nearly 50% of those suffering from a mental illness do not seek treatment. We believe the value proposition that CuraLinc offers helps to address some of the most critical issues in healthcare today. "Lightyear Capital invests in CuraLinc Healthcare" was originally created and published by Hospital Management, a GlobalData owned brand.The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.